ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 102,33
0,13%
Dow Jones
39 391,88
-0,70%
DAX
18 691,32
0,05%
Brent Oil
81,48
-0,06%
Bitcoin
67 885,98
-1,76%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Praxis Precision Medicines Inc (PRAX)

  7. Praxis Precision Medicines Inc (PRAX) Actualités

PRAX

Praxis Precision Medicines (PRAX)

Praxis Precision Medicines Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PRAX
DateHeureSourceTitreSymboleSociété
20/05/202414h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
13/05/202414h21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRAXPraxis Precision Medicines Inc
13/05/202414h18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRAXPraxis Precision Medicines Inc
12/04/202414h00GlobeNewswire Inc.Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual MeetingNASDAQ:PRAXPraxis Precision Medicines Inc
05/03/202415h08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PRAXPraxis Precision Medicines Inc
05/03/202413h33Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PRAXPraxis Precision Medicines Inc
05/03/202413h12Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PRAXPraxis Precision Medicines Inc
15/02/202402h45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PRAXPraxis Precision Medicines Inc
12/01/202423h20Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PRAXPraxis Precision Medicines Inc
10/01/202422h19GlobeNewswire Inc.Praxis Precision Medicines, Inc. Announces Proposed Public OfferingNASDAQ:PRAXPraxis Precision Medicines Inc
28/11/202313h00GlobeNewswire Inc.Praxis Precision Medicines to Showcase Largest Pipeline of Precision Epilepsy Programs and Breadth of Commitment to Epilepsy Treatments at Upcoming MeetingsNASDAQ:PRAXPraxis Precision Medicines Inc
21/11/202322h00GlobeNewswire Inc.Praxis Precision Medicines to Present at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:PRAXPraxis Precision Medicines Inc
16/11/202314h00GlobeNewswire Inc.Praxis Precision Medicines Receives PRIME Designation from the EMA for elsunersen (PRAX-222) for Treatment of SCN2A Gain of Function Developmental EpilepsiesNASDAQ:PRAXPraxis Precision Medicines Inc
07/11/202313h00GlobeNewswire Inc.Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2023 Financial ResultsNASDAQ:PRAXPraxis Precision Medicines Inc
02/11/202313h00GlobeNewswire Inc.Praxis Precision Medicines to Present at Truist Securities BioPharma SymposiumNASDAQ:PRAXPraxis Precision Medicines Inc
16/10/202313h09Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PRAXPraxis Precision Medicines Inc
04/10/202313h56Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PRAXPraxis Precision Medicines Inc
02/10/202319h17GlobeNewswire Inc.Praxis Precision Medicines Provides Portfolio Update at 2023 R&D DayNASDAQ:PRAXPraxis Precision Medicines Inc
27/09/202322h15GlobeNewswire Inc.Praxis Precision Medicines To Host Hybrid R&D Day on Monday, October 2, 2023NASDAQ:PRAXPraxis Precision Medicines Inc
19/09/202316h25AllPennyStocks.comBiotech Catches Major Premarket BidNASDAQ:PRAXPraxis Precision Medicines Inc
07/09/202314h00GlobeNewswire Inc.Praxis Precision Medicines to Present at H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:PRAXPraxis Precision Medicines Inc
31/08/202314h00GlobeNewswire Inc.Praxis Precision Medicines to Present Data from Epilepsy Portfolio at the 35th International Epilepsy CongressNASDAQ:PRAXPraxis Precision Medicines Inc
09/08/202313h00GlobeNewswire Inc.Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2023 Financial ResultsNASDAQ:PRAXPraxis Precision Medicines Inc
08/08/202313h00GlobeNewswire Inc.Praxis Precision Medicines Announces Positive Data from Randomized Withdrawal Sub-Study and Long-Term Extension of Essential1 Study for UlixacaltamideNASDAQ:PRAXPraxis Precision Medicines Inc
07/08/202313h00GlobeNewswire Inc.Praxis Precision Medicines Announces Positive Results of EEG Analysis of PRAX-628 Phase 1 StudyNASDAQ:PRAXPraxis Precision Medicines Inc
03/08/202322h12GlobeNewswire Inc.Praxis Precision Medicines to Participate at the 2023 Wedbush PacGrow Healthcare ConferenceNASDAQ:PRAXPraxis Precision Medicines Inc
30/06/202322h15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PRAXPraxis Precision Medicines Inc
28/06/202322h48Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PRAXPraxis Precision Medicines Inc
28/06/202322h48Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:PRAXPraxis Precision Medicines Inc
27/06/202316h02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRAXPraxis Precision Medicines Inc
 Showing the most relevant articles for your search:NASDAQ:PRAX

Dernières Valeurs Consultées

KOSPI
70102B96
KIM Luxembourg Core Offi...
LSE
NBDS
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés